Cardiac allograft vasculopathy:
- 1 August 2002
- journal article
- Published by Elsevier in Transplantation Proceedings
- Vol. 34 (5) , 1847-1849
- https://doi.org/10.1016/s0041-1345(02)03101-9
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Vasodilator Response to Nifedipine in Human Coronary Arteries with Endothelial DysfunctionJournal of Cardiovascular Pharmacology, 2002
- Simvastatin treatment is associated with improvement in coronary endothelial function and decreased cytokine activation in patients after heart transplantationJournal of the American College of Cardiology, 2001
- Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin siteNature Medicine, 2001
- Coronary Artery Disease in the Transplanted HeartAnnual Review of Medicine, 2000
- Impact of Prophylactic Immediate Posttransplant Ganciclovir on Development of Transplant AtherosclerosisCirculation, 1999
- Simvastatin Reduces Graft Vessel Disease and Mortality After Heart TransplantationCirculation, 1997
- Effect of Pravastatin on Outcomes after Cardiac TransplantationNew England Journal of Medicine, 1995
- Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipientsJournal of the American College of Cardiology, 1995
- An intravascular ultrasound study of the influence of angiotensin-converting enzyme inhibitors and calcium entry blockers on the development of cardiac allograft vasculopathyThe American Journal of Cardiology, 1995
- A Preliminary Study of Diltiazem in the Prevention of Coronary Artery Disease in Heart-Transplant RecipientsNew England Journal of Medicine, 1993